Vaccines have traditionally worked by teaching the immune system to recognize a specific virus or bacterium—in effect, ...
In a sudden reversal, the US Food and Drug Administration has agreed to review Moderna’s experimental mRNA influenza vaccine.
Imagine a world where influenza vaccines are no longer crafted based on educated guesswork but are instead precision-targeted against a wide array of viral strains. Scientists at the University of ...
In a major blow to vaccine development, the FDA said it will not review Moderna’s application for the first mRNA-based flu shot.
Competing with giants like Takeda and Moderna, the plucky biotech believes it has unlocked a future with an easy, yearly oral vaccine.
Norovirus is the leading cause of gastroenteritis and is responsible for hundreds of thousands of deaths every year. However, research progress into antiviral treatments and vaccines has been hindered ...